Atlas Trials

Guangzhou Jiayin Biotech Ltd

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Guangzhou Jiayin Biotech Ltd

RecordFirmDate
Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD (NCT07178249)Guangzhou Jiayin Biotech Ltd2025-10-16
To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD) (NCT06888492)Guangzhou Jiayin Biotech Ltd2025-03-28
A Long-term Follow up Study of EXG102-031 in Participants With wAMD (NCT06859515)Guangzhou Jiayin Biotech Ltd2025-03-13
Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy (NCT06888661)Guangzhou Jiayin Biotech Ltd2025-03-10
The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease (NCT06819514)Guangzhou Jiayin Biotech Ltd2025-03-01
A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA (NCT06588803)Guangzhou Jiayin Biotech Ltd2025-03-01
A Study of EXG102-031 in Participants With wAMD (NCT06183814)Guangzhou Jiayin Biotech Ltd2023-10-12
Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1 (NCT05614531)Guangzhou Jiayin Biotech Ltd2023-02-16
Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I (NCT06576388)Guangzhou Jiayin Biotech Ltd2022-01-21

Track Guangzhou Jiayin Biotech Ltd automatically

Every clearance here is in the API, with alerts when new ones post.